Back
Science

Australian Universities Awarded Over $34 Million in NHMRC Grants for Medical Research

Generated on: Last updated: 4 sources
View source

Over $34 Million in NHMRC Grants Awarded to University of Newcastle, HMRI, and University of Queensland Researchers

Researchers at the University of Newcastle, the Hunter Medical Research Institute (HMRI), and the University of Queensland (UQ) have been awarded a combined total of more than $34 million in grants from the National Health and Medical Medical Research Council (NHMRC). These significant funds are earmarked to support a diverse range of health and medical research projects.

The projects will focus on critical areas such as environmental chemicals, infectious diseases, neurological disorders, and cancer.

University of Newcastle and HMRI Secure Over $3.8 Million in Ideas Grants

Three dedicated research teams from the University of Newcastle and the Hunter Medical Research Institute (HMRI) have successfully secured NHMRC Ideas Grants totaling over $3.8 million. These grants are specifically allocated to advance projects that tackle fundamental scientific questions and address pressing health challenges.

Dr. Jacinta Martin ($1.8 million): PFAS Exposure and Dietary Intervention

This crucial project will delve into the effects of per- and polyfluoroalkyl substances (PFAS), a group of ubiquitous environmental chemicals, on the health of both parents and children during the perinatal period. PFAS exposure has been linked to pregnancy complications and developmental issues. The research aims to precisely clarify the biological mechanisms through which PFAS impact health and will also test a plant-based dietary intervention designed to reduce PFAS accumulation. The insights gained from this study are intended to inform future intervention strategies.

Dr. Guy Cameron ($1.3 million): Iron Levels and Infection Risk in Aboriginal Children

This study will investigate the intricate relationship between low iron levels during pregnancy and early life, and the subsequent risk of otitis media (middle ear infection) in children. Otitis media is a leading cause of preventable hearing loss and developmental delay, with particularly high rates observed among Aboriginal and Torres Strait Islander communities. The project seeks to understand how iron status influences immune responses and the prevalence of ear bacteria. The expected findings are anticipated to contribute significantly to improved prevention strategies, including targeted iron supplementation.

Professor Juanita Todd ($644,000): Early Brain Changes in Schizophrenia

This project focuses on identifying early changes in brain function, specifically impaired sensory gating, which may precede the onset of schizophrenia. While schizophrenia symptoms typically emerge in early adulthood, it is believed that subtle alterations in brain function occur much earlier. The research integrates human studies, laboratory investigations, and computational modeling to pinpoint the biological processes that disrupt sensory gating and increase vulnerability to the condition. The ultimate goal is to advance our understanding of schizophrenia's origins and to support enhanced monitoring and early intervention methods.

University of Queensland Researchers Receive $31 Million

The University of Queensland (UQ) has proudly announced that its researchers and teams have been awarded a substantial $29 million from NHMRC through both the Ideas Grants and Postgraduate Scholarships programs. Additionally, UQ received an extra $2 million from the NHMRC Development Grants scheme, bringing the university's total to an impressive $31 million.

The Development Grants are specifically designed to support early-stage health and medical projects that demonstrate a clear pathway to commercialization and hold significant potential for intellectual property.

NHMRC Ideas Grants Recipients and Projects (Selected):

  • Dr Matilde Balbi: Investigating induced brain rhythms to improve stroke recovery.
  • Dr Carlie Cullen: Examining brain insulation during development and its potential contribution to neurodevelopmental disorders like ADHD and autism.
  • Professor Luke Guddat: Developing a new antibiotic targeting an enzyme essential for microbes but absent in humans, for treatments of infections such as tuberculosis and candida.
  • Professor John Hooper: Testing a new breast cancer detection method using specific receptor targeting for PET scan identification.
  • Professor Kiarash Khosrotehrani: Researching mechanisms by which damaged cells outcompete healthy ones, with the goal of developing therapies to prevent skin cancer.
  • Dr Christopher McMillan: Formulating an RNA medicine platform designed for longer efficacy, smaller doses, and rapid production for disease and pandemic response.
  • Dr Christian Nefzger: Studying how aging increases the risk and severity of fatty liver disease and developing new treatments using drugs and RNA technology.
  • Professor Avril Robertson: Designing new drugs to block a venom enzyme, aiming to treat dangerous recluse spider bites.
  • Professor Mark Schembri: Investigating a new drug-resistant E. coli strain that causes urinary tract infections and sepsis, to address growing antibiotic resistance.
  • Professor H. Peter Soyer: Utilizing 3D body photography, AI, and genomics to identify high-risk skin areas for earlier melanoma detection.
  • Associate Professor Susannah Tye: Developing an adaptive deep brain stimulation system for conditions like Parkinson's disease.
  • Professor Brandon Wainwright: Developing an mRNA vaccine to improve outcomes for children with brain cancer.
  • Associate Professor Timothy Wells: Researching a 'superbug' bacteria that evades antibiotics to enhance strategies against drug-resistant infections.
  • Professor Nick West: Studying how tuberculosis bacteria utilize specific survival systems to improve treatment or prevent infection.
  • Dr Sarah Withey: Growing miniature livers and brains to test treatments for Ataxia Telangiectasia, a childhood disease.
  • Associate Professor Steven Zuryn: Leading projects examining the spread of mitochondrial DNA mutations within cells and how environmental bacteria can reduce these mutations.

NHMRC Postgraduate Scholarships Recipients and Projects (Selected):

  • Dr Douglas Drak: Testing an optimized electronic frailty index to estimate in-hospital improvements in health outcomes.
  • Emilia Janca: Co-leading a model to enhance the mental health and wellbeing of people released from prison.

NHMRC Development Grants Recipients and Projects:

  • Professor Gregory Monteith: Focused on improving an existing therapy for the treatment of advanced and refractory prostate cancer.
  • Associate Professor David Muller: Working on the development of needle-free mRNA vaccines designed for protection from and treatment of HER2+ breast cancer.